Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 532 days ago

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

RTTNews | 688 days ago

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 804 days ago

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 1178 days ago

DAX Retreats After Positive Start, Down Nearly 0.5%

German stocks are swinging between gains and losses in cautious trade on Thursday with investors digesting the news about U.S. President Donald Trump signing the short-term funding bill that brings an end to the government shutdown, and looking ahead to some key U.S. economic data.

RTTNews | 1h 21min ago

Eurozone Industrial Production Rises Less Than Forecast

Eurozone industrial production recovered at a moderate pace in September largely driven by the rebound in energy output, official data showed on Thursday. Industrial production grew at a slower-than-expected pace of 0.2 percent in September from August, Eurostat revealed. Output was forecast to grow 0.7 percent, reversing a 1.1 percent fall in August.

RTTNews | 1h 31min ago

Sensex, Nifty Fail To Hold Early Gains, Settle Roughly Flat

Despite a fairly strong spell in positive territory that lasted close to four hours, Indian equity benchmark Sensex and the Nifty50 settled just marginally up on Thursday as several stocks pared early gains due to a sell-off in the final hour of the day's trading session.

RTTNews | 1h 47min ago

Asian Markets Close Mostly Higher

Broadly positive sentiment prevailed in Asian markets tracking the positive sentiment created by the end of the longest-ever U.S. government shutdown.

RTTNews | 2h 4min ago

EURUSD	1.16147	GBPUSD	1.31564	AUDUSD	0.65671
USDJPY	154.73	USDCAD	1.39934	USDCHF	0.79564